dr. J.F. Swart
Assistant Professor - medical
- Immunology patient care
Contact
Biography
Joost Swart is a board certified paediatrician immunologist & rheumatologist. After receiving his Medical Degree (cum laude/ with Honour) from the University of Groningen in 1999, he finished his training as a paediatrician at the VU Medical Center in Amsterdam in 2006. His fellowship paediatric rheumatology-immunology was completed in 2008 in Utrecht. He worked as a paediatric rheumatologist for 3 years in both Reade and the VUmc in Amsterdam. In 2011 he came to work in the largest Dutch group of Pediatric Rheumatology / Immunology based in Utrecht.
He is member of the Paediatric Educational Committee in Utrecht (PAOK-committee) and educates students in both the CRU and Summa medical curricula in Utrecht and lectures nurses in the Amstel Academy. He trains interns, residents and fellows in paediatrics and rheumatology in UMC Utrecht. He is a certified instructor on the APLS-course from the Advance Life Support Group in Belgium.
His research focuses on comparative effectiveness and safety of drugs and treatment-strategies in juvenile idiopathic arthritis (JIA). He is doing a PhD on the effect of mesenchymal stem cells in proteoglycan induced arthritis and has already started a phase I/II pilot-study in JIA-patients. Furthermore he is researcher and member of the Steering Committee of the international Pharmacovigilance database Pharmachild with over 9000 JIA-patients who have contributed their clinical data and over 1,700 blood and synovial samples. With this project he won the EULAR Abstract Award for top clinical research abstracts (6 out of 4300 abstracts).
He won a Pfizer Aspire-grant to investigate the treatment-results measured by JADAS-scores in JIA patients in Utrecht. He hopes to finish his PhD in the end of 2016.
He is member of the Dutch Rheumatology Association, Dutch Association for Paediatric Rheumatology, Paediatric Rheumatology European Society, Pediatric Rheumatology International Trial Organization and the Dutch Association against Quackery.
Side Activities
2015- present Maxima Medisch Centrum, Veldhoven: poli kinderreumatologie: 1 dag per maand
2014- Present Member of PAOK committee (Education for Pediatricians) UMC Utrecht
2014- Present Coordinator Pharmachild-NL
2011- Present Member of Steering Committee of PharmaChild (International)
Fellowship and Awards
2015 “The Addition of one or more Biologics to Methotrexate in Children with JIA increases the Incidence of
Infections and Serious Adverse Events. The 5882 Pharmachild Cohort.” Selected as Top 6 of Clinical
Science Abstracts chosen from 4323 Abstracts EULAR Congress Rome
2010 “Mesenchymal Stem Cell Therapy has significant Clinical and Histopathological Effect in Proteoglycan
Induced Arthritis” Selected as Top 25 of Basic Science Abstracts chosen from 3,508 Abstracts EULAR
Congress Rome
2009 Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics, VUmc Amsterdam
2002 Resident Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics,
Deventer Hospitals, NL
Research Output (71)
Fatigue in Children Post-Cancer Treatment and Other Long-Term Diseases
Nap-Van der Vlist M., Dalmeijer G., Grootenhuis M., van der Ent C., van den Heuvel-Eibrink M., Wulffraat N., Swart J., van Litsenburg R., van de Putte E., Nijhof S. dec 2019, In: Pediatric Blood & Cancer. 66 , p. S150-S151
Immunogenicity of biologic agents in juvenile idiopathic arthritis:A systematic review and meta-analysis
Doeleman Martijn J.H., Van Maarseveen Erik M., Swart Joost F. 1 okt 2019, In: Rheumatology (United Kingdom). 58 , p. 1839-1849 11 p.
Fatigue in childhood chronic disease
Nap-Van Der Vlist Merel M., Dalmeijer Geertje W., Grootenhuis Martha A., Van Der Ent Cornelis K., Van Den Heuvel-Eibrink Marry M., Wulffraat Nico M., Swart Joost F., Van Litsenburg Raphaële R.L., Van De Putte Elise M., Nijhof Sanne L. 7 jun 2019, In: Archives of Disease in Childhood. 104 , p. 1090-1095 6 p.
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design:An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO
Ramanan A. V., Hampson L. V., Lythgoe H., Jones A. P., Hardwick B., Hind H., Jacobs B., Vasileiou D., Wadsworth I., Ambrose N., Davidson J., Ferguson P. J., Herlin T., Kavirayani A., Killeen O. G., Compeyrot-Lacassagne S., Laxer R. M., Roderick M., Swart J. F., Hedrich C. M., Beresford M. W. 1 jun 2019, In: PLoS ONE. 14
HOME MONITORING OF INACTIVE DISEASE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: PREDICTIVE VALUE OF EQ-5D-5L-Y
Doeleman Martijn J. H., De Roock Sytze, Buijsse Nathan, Klein Mark, Bonsel Gouke J., Seyfert V., Wulffraat Nico, Swart Joost F. jun 2019, In: Annals of the Rheumatic Diseases. 78 , p. 1336-1336
DEVELOPMENT OF A PREDICTIVE TOOL FOR RESPONSE TO ANTI-TNF-ALPHA THERAPY IN JIA USING GENE EXPRESSION PROFILES IN PERIPHERAL DERIVED MONONUCLEAR CELLS
Baaij Jedidja, Scholman Rianne, Yeung Rae, Duong Trang, Wulffraat Nico, Swart Joost F., Vastert Sebastian, De Roock Sytze jun 2019, In: Annals of the Rheumatic Diseases. 78 , p. 554-554
SERIOUS/AT LEAST MODERATE INFECTIONS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS ON SYNTHETIC AND BIOLOGIC DRUGS FROM THE PHARMACHILD REGISTRY
Giancane Gabriella, Swart Joost F., Tzaribachev Nikolay, Rubio Nadina, Cuttica Ruben, Rumba-Rozenfelde Ingrida, Suwairi Wafaa Mohammed Saad, Lazar Calin, Uziel Yosef, Telcharova Albena, Avcin Tadej, Minaici Angela, Len Claudio, Garay Stella Maris, Boteanu Alina, Pistorio Angela, Wulffraat Nico, Ruperto Nicolino jun 2019, In: Annals of the Rheumatic Diseases. 78 , p. 629-629
THE CONSEQUENCES OF THE PROVISIONAL PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION JUVENILE IDIOPATHIC ARTHRITIS CLASSIFICATION CRITERIA
Mars Vera, Swart Joost F., Giancane Gabriella, De Roock Sytze, Estmann Anne, Jelusic Marija, Ruzafa Estefania Moreno, de Inocencio Jaime, Vojinovic Jelena, Remesal Agustin, Laday M., Cimaz Rolando, Cochino A. V., Calvo Inmaculada, Harjacek M., Wulffraat Nico, Ruperto Nicolino jun 2019, In: Annals of the Rheumatic Diseases. 78 , p. 2000-2000
DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE DURING TREATMENT WITH ETANERCEPT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
Krol Roline, Swart Joost F., Giancane Gabriella, De Roock Sytze, Herlin Troels, Dolezalova Pavla, Sanner Helga, Susic Gordana, Sztajnbok Flavio R., Maritsi D., Constantin Tamas, Vargova V., Sawhney Sujata, Rygg Marite, Oliveira Sheila Knupp D. E., Cattalini Marco, Nordal Ellen, Magalhaes Claudia, Martini Alberto, Wulffraat Nico, Ruperto Nicolino jun 2019, p. 100-101
Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis:A scoping review
Kip Michelle M.A., Currie Gillian, Marshall Deborah A., Grazziotin Lago Luiza, Twilt Marinka, Vastert Sebastiaan J., Swart Joost F., Wulffraat Nico, Yeung Rae S.M., Benseler Susanne M., Ijzerman Maarten J., Bonsel Gouke, Feldman Brian M., Hoppenreijs Esther, Lang Bianca, Leblanc Claire, Sepulveda Ana, Toupin-April Karine, Van Pelt Philomine, Van Royen-Kerkhof Annet 6 mei 2019, In: Pediatric Rheumatology. 17 13 p.